Cargando…

HAM/TSP introduction: systematic review of HAM/TSP clinical trials

Detalles Bibliográficos
Autores principales:	Anderson, Rebecca, Martin, Fabiola
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2014
Materias:	Oral Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4044304/ http://dx.doi.org/10.1186/1742-4690-11-S1-O26

Ejemplares similares

Clinical features of familial HAM/TSP
por: Nozuma, Satoshi, et al.
Publicado: (2014)

HTLV-1 proviral load as an indicative marker of HAM/TSP: a systematic review of studies of patients with HAM/TSP
por: Bassi, Shiva Shaan, et al.
Publicado: (2014)

HAM/TSP in relatives of HAM/TSP cases and in relatives of asymptomatic HTLV-1 carriers
por: Alvarez, Carolina, et al.
Publicado: (2014)

Characterization of glycans of CD4+T cells in HAM/TSP
por: Kodama, Daisuke, et al.
Publicado: (2014)

Monocyte accumulation is an early event in HAM/TSP pathogenesis, while monocyte activation and IFN-regulated gene expression persist in chronic HAM/TSP
por: Menezes, Soraya Maria, et al.
Publicado: (2015)

Managing HAM/TSP with Fampridine
por: Menna-Barreto, M Marcio
Publicado: (2014)

Through the looking glass: CNS imaging findings in HAM/TSP
por: Massoud, Raya
Publicado: (2014)

Evaluation of clinical outcome measures for HAM/TSP
por: Kikuchi, Takayuki, et al.
Publicado: (2015)

A NKG2D Thr72Ala polymorphism is not associated with HAM/TSP and proviral load values in Peruvian HTLV-1 infected patients with HAM/TSP and asymptomatic carriers
por: Bernia, Cynthia, et al.
Publicado: (2015)

Anti-CD3 monoclonal antibody as a possible therapeutic alternative in HAM/TSP
por: Van Weyenbergh, Johan, et al.
Publicado: (2014)

HTLV-1 proviral load of HAM/TSP patients according to new diagnostic criteria of HAM/TSP
por: Grassi, Maria F R, et al.
Publicado: (2011)

Contribution of galvanic vestibular stimulation for the diagnosis of HAM/TSP
por: Cunha, Luciana, et al.
Publicado: (2014)

Wish list: which biomarker studies in HAM/TSP should be funded by the God of all trial funds?
por: Yamano, Yoshihisa
Publicado: (2014)

Clinical trial of raltegravir, an integrase inhibitor, in HAM/TSP
por: Enose‐Akahata, Yoshimi, et al.
Publicado: (2021)

Will our dreams ever come true: treatment options for patients with HAM/TSP in 10 years
por: Pise-Masison, Cynthia
Publicado: (2014)

Characteristics of HAM/TSP after kidney transplantation from HTLV-1 positive living donors
por: Kimura, Miyuna, et al.
Publicado: (2015)

Is age an effect modifier in the relationship between HAM / TSP and depression?
por: Boa-Sorte, Ney, et al.
Publicado: (2014)

Management of HAM/TSP: Systematic Review and Consensus-based Recommendations 2019
por: Araujo, Abelardo, et al.
Publicado: (2021)

Recent epidemiologic trends of HAM/TSP in Japan
por: Matsuzaki, Toshio, et al.
Publicado: (2011)

HAM/TSP and major depression: the role of age
por: Boa-Sorte, Ney, et al.
Publicado: (2015)

HTLV-1 epigenetic modification of the FoxP3 TSDR in HAM/TSP decreases the functional proliferative suppression of Tregs
por: Anderson, Monique R, et al.
Publicado: (2014)

Correlation of increased CXCL13 with intrathecal humoral immune responses to HTLV-1 in CSF of patients with HAM/TSP
por: Enose-Akahata, Yoshimi, et al.
Publicado: (2014)

Vestibulospinal tract dysfunction in HTLV-1-asymptomatic infection and in HAM/TSP
por: Labanca, Ludimila, et al.
Publicado: (2014)

Temporal Trends in HAM/TSP incidence in Martinique over 25 years (1986-2010): dramatic decrease since 2000
por: Olindo, Stephane, et al.
Publicado: (2015)

Molecular and clinical analyses of HTLV-1 subgroups associated with the risk of developing HAM/TSP.
por: Saito, Mineki, et al.
Publicado: (2015)

HAM/TSP patient treated with porcine cortex monosialoganglioside: clinical outcome and follow up
por: Cánepa, Camila, et al.
Publicado: (2015)

Lack of recall response to Tax in ATL and HAM/TSP patients but not in asymptomatic carriers of human T-cell leukemia virus type 1
por: Manuel, Sharrón L, et al.
Publicado: (2014)

Clinical subtype of HAM/TSP based on clinical course and laboratory findings
por: Yamano, Yoshihisa, et al.
Publicado: (2011)

Deep sequencing of the TCRβ repertoire reveals T cell clonal expansion is associated with HTLV-1 proviral load in HAM/TSP patients
por: Sousa, Alessandra de Paula A, et al.
Publicado: (2015)

Detrusor Arreflexia as an End Stage of Neurogenic Bladder in HAM/TSP?
por: Tannus, Matheus, et al.
Publicado: (2011)

B cell costimulatory molecules as potential biomarkers in HAM/TSP
por: Menezes, Soraya M, et al.
Publicado: (2011)

Role of HTLV-1 Tax and HBZ in the Pathogenesis of HAM/TSP
por: Enose-Akahata, Yoshimi, et al.
Publicado: (2017)

Association Between HTLV-1 Genotypes and Risk of HAM/TSP
por: Saito, Mineki
Publicado: (2019)

What is the role of the thioredoxin antioxidant complex in relation to HAM/TSP?
por: Youssefi, Masoud, et al.
Publicado: (2020)

Identification of miRnas with possible prognostic roles for HAM/TSP
por: de Souza, Daniela Raguer Valadão, et al.
Publicado: (2023)

Early diagnosis of HTLV-1-associated myelopathy (HAM/TSP) in HTLV-1 carrier clinic
por: Matsuzaki, Toshio, et al.
Publicado: (2014)

Proteomic profiles among asymptomatic HTLV-1 carriers and HAM/TSP patients in Peru
por: Temoche, Morayma, et al.
Publicado: (2014)

Virus-induced CXCL10-CXCR3 positive feedback loop via astrocytes is critical for maintaining chronic inflammatory lesions in HAM/TSP
por: Sato, Tomoo, et al.
Publicado: (2014)

Clinical trial of a humanized monoclonal anti-IL15Rβ (CD122), in HTLV-1 associated myelopathy/ tropical spastic paraparesis (HAM/TSP)
por: Massoud, Raya, et al.
Publicado: (2014)

Clinical manifestations in HTLV-1 infected individuals without HAM/TSP: Results of an 8 years cohort
por: Tanajura, Davi, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_eaqnalsg3c7c0vi34atsanj0s4